Glucagen Hypokit — supply status, manufacturers & alternatives

Glucagen Hypokit

—

🇦🇺 AUST R 47105 · Novo Nordisk Pharmaceuticals Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇳🇿 NZ

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Glucagen Hypokit
Therapeutic category	Auto-created by AIFA — Difetti di qualità (Italy) scraper
Controlled substance	No

Registrations on file	2

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇳🇿

New Zealand

ATC/DDD · 1mo ago

High

Recalls official enforcement reports

🇳🇿

Glucagen Hypokit

Novo Nordisk A/S · Sept 2016

Class Idetails ↗

🇮🇹

Glucagen Hypokit

Sept 2016

Class ?details ↗

Verified timeline regulator events

🇳🇿 9 Sept 2016

high reported

Sources official regulators

🇳🇿

ATC/DDD

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
GLUCAGEN HYPOKIT glucagon	1mg	—	🇦🇺 AU	Novo Nordisk Pharmaceuticals Pty Ltd	Active
GLUCAGEN HYPOKIT	—	kit	🇨🇦 CA	NOVO NORDISK CANADA INC	Cancelled

Mederti Drug Report

Generated 7 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.